Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Risk of endometrial carcinoma associated with BRCA mutation.

Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J.

Gynecol Oncol. 2001 Mar;80(3):395-8.

PMID:
11263938
2.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J.

J Clin Oncol. 2003 Nov 15;21(22):4222-7. Review.

PMID:
14615451
3.
4.

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E.

Gynecol Oncol. 1999 Nov;75(2):300-4. Review.

PMID:
10525392
5.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Welcsh PL, King MC.

Hum Mol Genet. 2001 Apr;10(7):705-13. Review.

PMID:
11257103
6.

Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.

Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S, Klein C, Sitarik M, Deffenbaugh AM, Graw SL.

Cancer. 2003 Aug 1;98(3):597-602. Review.

7.

Hereditary ovarian cancer in Ashkenazi Jews.

Robles-Díaz L, Goldfrank DJ, Kauff ND, Robson M, Offit K.

Fam Cancer. 2004;3(3-4):259-64. Review.

PMID:
15516850
8.

Ethnic differences in cancer risk resulting from genetic variation.

Neuhausen SL.

Cancer. 1999 Dec 1;86(11 Suppl):2575-82. Review.

PMID:
10630184
9.

Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk.

Rebbeck TR.

Environ Mol Mutagen. 2002;39(2-3):228-34. Review.

PMID:
11921193
10.

Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.

Robson M.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):113S-8S. Review.

PMID:
11060338
11.

BRCA-associated cancer risk: molecular biology and clinical practice.

van Golen K, Milliron K, Davies S, Merajver SD.

J Lab Clin Med. 1999 Jul;134(1):11-8. Review. No abstract available.

PMID:
10402055
12.

Current concepts in the pathology and epigenetics of endometrial carcinoma.

Arafa M, Somja J, Dehan P, Kridelka F, Goffin F, Boniver J, Delvenne P.

Pathology. 2010 Dec;42(7):613-7. doi: 10.3109/00313025.2010.520307. Review.

PMID:
21080868
13.

Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report.

de Jonge MM, Mooyaart AL, Vreeswijk MP, de Kroon CD, van Wezel T, van Asperen CJ, Smit VT, Dekkers OM, Bosse T.

Eur J Cancer. 2017 Feb;72:215-225. doi: 10.1016/j.ejca.2016.11.028. Epub 2016 Dec 31. Review.

PMID:
28049106
14.

Genetics of endometrial cancer.

Shai A, Segev Y, Narod SA.

Fam Cancer. 2014 Sep;13(3):499-505. doi: 10.1007/s10689-014-9722-7. Review.

PMID:
24838932
15.

The Consequences of a BRCA Mutation in Women.

Famorca-Tran J, Roux G.

J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1. Review. No abstract available.

Supplemental Content

Support Center